| 1 | Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells | 2.5 | 0 | Citations (PDF) |
| 2 | Hypoparathyroidism Associated with Benign Thyroid Nodules in
DiGeorge-like Syndrome: A Rare Case Report and Literature Review | 2.0 | 1 | Citations (PDF) |
| 3 | Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells | 4.4 | 7 | Citations (PDF) |
| 4 | Does thyroglossal duct arborization play a role in the post-surgical outcome of Sistrunk procedure in children? | 1.6 | 2 | Citations (PDF) |
| 5 | Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro | 4.4 | 10 | Citations (PDF) |
| 6 | Cryopreserved Thyroid Tissue Autotransplant in Pediatric Age Patients: A Feasibility Study and Literature Review | 3.8 | 1 | Citations (PDF) |
| 7 | The Potential Therapeutic Value of Aspirin in Anaplastic Thyroid Cancer | 3.8 | 1 | Citations (PDF) |
| 8 | Late diagnosis of ureteral injury from anterior lumbar spine interbody fusion surgery: Case report and literature review | 0.6 | 11 | Citations (PDF) |
| 9 | Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture | 4.4 | 8 | Citations (PDF) |
| 10 | Increased neutrophil derived chemokines (CXCL10 and CCL2) in human trichinellosis as possible serological markers of the polarization of the immune response against the parasite | 3.5 | 5 | Citations (PDF) |
| 11 | Insights on the Association between Thyroid Diseases and Colorectal Cancer | 2.5 | 8 | Citations (PDF) |
| 12 | Thyroid Metastasis from Primary Breast Cancer | 2.5 | 11 | Citations (PDF) |
| 13 | Low glomerular filtration rate values are associated with higher TSH in an elderly population at high cardiovascular disease risk | 3.8 | 6 | Citations (PDF) |
| 14 | Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer | 4.9 | 21 | Citations (PDF) |
| 15 | DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review | 3.8 | 9 | Citations (PDF) |
| 16 | Thyroid Autoimmunity and SARS-CoV-2 Infection | 2.5 | 32 | Citations (PDF) |
| 17 | Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase | 3.2 | 6 | Citations (PDF) |
| 18 | Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review | 3.0 | 15 | Citations (PDF) |
| 19 | Molecular targets of tyrosine kinase inhibitors in thyroid cancer | 13.7 | 138 | Citations (PDF) |
| 20 | MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma | 1.7 | 10 | Citations (PDF) |
| 21 | Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin | 13.7 | 24 | Citations (PDF) |
| 22 | Psychological profile and unexpected pain in oral lichen planus: A case–control multicenter SIPMO study
a | 2.5 | 28 | Citations (PDF) |
| 23 | The microbiological profile of patients with Fournier’s gangrene: A retrospective multi-institutional cohort study | 0.6 | 5 | Citations (PDF) |
| 24 | Is off‐clamp robot‐assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial | 3.2 | 101 | Citations (PDF) |
| 25 | Neutrophil extracellular traps in cancer | 13.7 | 203 | Citations (PDF) |
| 26 | E-scooter accidents: A rising cause of kidney injury | 0.6 | 4 | Citations (PDF) |
| 27 | Randomized trials to determine the ideal management of the renal artery during partial nephrectomy: Life’s under no obligation to give us what we expect | 1.7 | 9 | Citations (PDF) |
| 28 | Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment | 7.9 | 150 | Citations (PDF) |
| 29 | Simultaneous robotic partial nephrectomy for bilateral renal masses | 2.2 | 9 | Citations (PDF) |
| 30 | Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis | 3.8 | 20 | Citations (PDF) |
| 31 | Usefulness of Magnetic Mallet in Oral Surgery and Implantology: A Systematic Review | 2.4 | 37 | Citations (PDF) |
| 32 | Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies | 2.1 | 12 | Citations (PDF) |
| 33 | Factors associated with postoperative hypocalcemia following thyroidectomy in childhood | 1.3 | 9 | Citations (PDF) |
| 34 | Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy | 3.8 | 13 | Citations (PDF) |
| 35 | Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini’s nomogram on the RECORD2 project cohort | 1.7 | 19 | Citations (PDF) |
| 36 | Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics | 3.8 | 10 | Citations (PDF) |
| 37 | Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium) | 2.5 | 10 | Citations (PDF) |
| 38 | Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer | 4.4 | 17 | Citations (PDF) |
| 39 | Fish and the Thyroid: A Janus Bifrons Relationship Caused by Pollutants and the Omega-3 Polyunsaturated Fatty Acids | 3.8 | 28 | Citations (PDF) |
| 40 | Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer | 1.8 | 8 | Citations (PDF) |
| 41 | Myoinositol in Autoimmune Thyroiditis | 3.8 | 20 | Citations (PDF) |
| 42 | Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases | 6.6 | 18 | Citations (PDF) |
| 43 | Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis | 4.9 | 3 | Citations (PDF) |
| 44 | Increased trend of thyroid cancer in childhood over the last 30 years in EU countries: a call for the pediatric surgeon | 2.1 | 20 | Citations (PDF) |
| 45 | Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review | 2.9 | 16 | Citations (PDF) |
| 46 | ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4 | 0.3 | 0 | Citations (PDF) |
| 47 | PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4 | 0.3 | 0 | Citations (PDF) |
| 48 | Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project) | 3.5 | 38 | Citations (PDF) |
| 49 | Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-assisted Partial Nephrectomy: Results of a Multicenter Series | 3.5 | 44 | Citations (PDF) |
| 50 | Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors | 3.5 | 54 | Citations (PDF) |
| 51 | Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation Between Ischemia Time and Patient Health Status (RECORD2 Project) | 5.8 | 19 | Citations (PDF) |
| 52 | Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients | 4.4 | 70 | Citations (PDF) |
| 53 | The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study | 3.2 | 36 | Citations (PDF) |
| 54 | The pathogenic role of circulating Hashimoto's Thyroiditis‐derived TPO‐positive IgG on fetal loss in naïve mice | 2.1 | 7 | Citations (PDF) |
| 55 | A Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of a Single Oral Dose of 5-HT1A Antagonist GSK958108 on Ejaculation Latency Time in Male Patients Suffering From Premature Ejaculation | 0.5 | 8 | Citations (PDF) |
| 56 | Nomogram predicting 30‐day mortality after nephrectomy in the contemporary era: Results from the SEER database | 1.7 | 7 | Citations (PDF) |
| 57 | The Role of Emotional Condition in Patients With Lower Urinary Tract Symptoms Performing Uroflowmetry | 1.4 | 10 | Citations (PDF) |
| 58 | Frailty impact on postoperative complications and early mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review | 1.2 | 48 | Citations (PDF) |
| 59 | Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study | 1.8 | 11 | Citations (PDF) |
| 60 | Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project) | 3.5 | 104 | Citations (PDF) |
| 61 | Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer | 1.2 | 9 | Citations (PDF) |
| 62 | Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis | 3.0 | 13 | Citations (PDF) |
| 63 | Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study | 2.7 | 57 | Citations (PDF) |
| 64 | Predictors of complications occurring after open and robot-assisted prostate cancer surgery: a retrospective evaluation of 1062 consecutive patients treated in a tertiary referral high volume center | 2.1 | 13 | Citations (PDF) |
| 65 | L-T4 Therapy in Enteric Malabsorptive Disorders | 3.8 | 21 | Citations (PDF) |
| 66 | Radical prostatectomy technique in the robotic evolution: from da Vinci standard to single port—a single surgeon pathway | 2.1 | 25 | Citations (PDF) |
| 67 | The Association of Myo-Inositol and Selenium Contrasts Cadmium-Induced Thyroid C Cell Hyperplasia and Hypertrophy in Mice | 3.8 | 17 | Citations (PDF) |
| 68 | Deviation from the Protocol of a Randomized Clinical Trial Comparing On-Clamp versus Off-Clamp Laparoscopic Partial Nephrectomy (CLOCK II Laparoscopic Study): A Real-Life Analysis | 4.2 | 14 | Citations (PDF) |
| 69 | The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine | 3.8 | 29 | Citations (PDF) |
| 70 | Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study | 4.0 | 13 | Citations (PDF) |
| 71 | Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) | 5.8 | 32 | Citations (PDF) |
| 72 | Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy | 3.8 | 41 | Citations (PDF) |
| 73 | Low-intensity extracorporeal shock wave therapy (Li-ESWT) for priapism-induced erectile dysfunction in young patients: the first case series | 1.6 | 4 | Citations (PDF) |
| 74 | Comparison between thulium laser vapoenucleation and plasmakinetic resection of the prostate in men aged 75 years and older in a real-life setting: a propensity score analysis | 2.7 | 7 | Citations (PDF) |
| 75 | The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy | 0.3 | 0 | Citations (PDF) |
| 76 | Serum TSH Levels Normalisation in Patients Affected by Autoimmune Atrophic Gastritis, After the Switch From Oral L-T4 in Tablet Form to L-T4 in Liquid Formulation | 0.3 | 0 | Citations (PDF) |
| 77 | Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis | 2.6 | 16 | Citations (PDF) |
| 78 | Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance | 0.3 | 1 | Citations (PDF) |
| 79 | Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology | 3.5 | 61 | Citations (PDF) |
| 80 | Omics in urology: An overview on concepts, current status and future perspectives | 0.6 | 10 | Citations (PDF) |
| 81 | Robot-assisted vesico-vaginal fistula repair: technical nuances | 2.1 | 9 | Citations (PDF) |
| 82 | The bladder-flap ureteral augmentation: An original solution in case of complex distal stricture | 0.4 | 0 | Citations (PDF) |
| 83 | A Risk-Group Classification Model in Patients with Bladder Cancer Under Neoadjuvant Cisplatin-Based Combination Chemotherapy | 2.3 | 5 | Citations (PDF) |
| 84 | Does Maxillary Retrusion in Skeletal Class III Malocclusion Affect the Perception of Facial Aesthetics? Evaluation of Different Groups | 1.2 | 0 | Citations (PDF) |
| 85 | Extrahepatic Manifestations of Chronic HCV Infection | 34.5 | 11 | Citations (PDF) |
| 86 | Neutrophil percentage-to-albumin Ratio Predicts Mortality in Bladder Cancer Patients Treated With Neoadjuvant Chemotherapy Followed By Radical Cystectomy | 1.8 | 76 | Citations (PDF) |
| 87 | Management of local recurrence after radical nephrectomy: surgical removal with or without systemic treatment is still the gold standard. Results from a multicenter international cohort | 1.4 | 10 | Citations (PDF) |
| 88 | Urodynamics criteria of detrusor underactivity in women underwent middle urethral sling for stress urinary incontinence: What is the clinical role? | 1.7 | 6 | Citations (PDF) |
| 89 | Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) | 4.4 | 28 | Citations (PDF) |
| 90 | Expression and Clinical Utility of Transcription Factors Involved in Epithelial–Mesenchymal Transition during Thyroid Cancer Progression | 2.5 | 23 | Citations (PDF) |
| 91 | Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer | 3.9 | 6 | Citations (PDF) |
| 92 | Does Mandibular Gonial Angle Influence the Eruption Pattern of the Lower Third Molar? A Three-Dimensional Study | 2.5 | 36 | Citations (PDF) |
| 93 | Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation | 0.9 | 15 | Citations (PDF) |
| 94 | Perioperative outcomes of patients undergoing urological elective surgery during the COVID-19 pandemic: a national overview across 28 Italian institutions | 0.5 | 4 | Citations (PDF) |
| 95 | Slit2 Regulation of Hyaluronan and Cytokine Synthesis in Fibrocytes in Thyroid-associated Ophthalmopathy | 4.0 | 4 | Citations (PDF) |
| 96 | Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer | 1.4 | 7 | Citations (PDF) |
| 97 | A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination | 6.6 | 80 | Citations (PDF) |
| 98 | Precision Medicine in Graves’ Disease and Ophthalmopathy | 3.8 | 27 | Citations (PDF) |
| 99 | A New Combined Protocol to Treat the Dentin Hypersensitivity Associated with Non-Carious Cervical Lesions: A Randomized Controlled Trial | 2.1 | 27 | Citations (PDF) |
| 100 | Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis | 1.0 | 5 | Citations (PDF) |
| 101 | Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism | 3.8 | 34 | Citations (PDF) |
| 102 | External validation of the Palacios’ equation: a simple and accurate tool to estimate the new baseline renal function after renal cancer surgery | 2.2 | 12 | Citations (PDF) |
| 103 | Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups | 6.6 | 110 | Citations (PDF) |
| 104 | Wound dehiscence prevalence and relationship with prosthetic material extrusion in women underwent anterior colpotomy | 3.0 | 0 | Citations (PDF) |
| 105 | The Predictive Role of Biomarkers for the Detection of Acute Kidney Injury After Partial or Radical Nephrectomy: A Systematic Review of the Literature | 3.5 | 41 | Citations (PDF) |
| 106 | Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group | 3.5 | 29 | Citations (PDF) |
| 107 | Thyroid autoimmune disorders and cancer | 13.7 | 161 | Citations (PDF) |
| 108 | Near-infrared Fluorescence Imaging with Indocyanine Green in Robot-assisted Partial Nephrectomy: Pooled Analysis of Comparative Studies | 3.5 | 50 | Citations (PDF) |
| 109 | Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer | 5.8 | 51 | Citations (PDF) |
| 110 | Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients | 1.8 | 24 | Citations (PDF) |
| 111 | Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy | 2.1 | 61 | Citations (PDF) |
| 112 | Recurrent Pregnancy Loss in Women with Hashimoto's Thyroiditis with Concurrent Non-Endocrine Autoimmune Disorders | 4.4 | 22 | Citations (PDF) |
| 113 | A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality | 2.3 | 14 | Citations (PDF) |
| 114 | Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study | 2.3 | 12 | Citations (PDF) |
| 115 | Segmental Ureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis of Comparative Studies | 2.3 | 38 | Citations (PDF) |
| 116 | A Prospective Comparative Study of the Feasibility and Reliability of Telephone Follow-Up in Female Urology: The Patient Home Office Novel Evaluation (PHONE) Study | 1.4 | 22 | Citations (PDF) |
| 117 | External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers | 2.2 | 8 | Citations (PDF) |
| 118 | Primary lymphomas of the genitourinary tract: A population-based study | 1.7 | 11 | Citations (PDF) |
| 119 | New insight in endocrine-related adverse events associated to immune checkpoint blockade | 5.1 | 95 | Citations (PDF) |
| 120 | Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis | 3.5 | 97 | Citations (PDF) |
| 121 | Novel therapies for thyroid autoimmune diseases: An update | 5.1 | 42 | Citations (PDF) |
| 122 | Th1 Chemokines in Autoimmune Endocrine Disorders | 4.0 | 90 | Citations (PDF) |
| 123 | Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit | 2.5 | 7 | Citations (PDF) |
| 124 | Cystocele Repair by a Modified Surgical Technique of Bilateral Pubococcygeus Plication: Long-Term Surgical and Functional Results | 2.5 | 7 | Citations (PDF) |
| 125 | Bladder cancer incidence rates and trends in young adults aged 20-39 years | 1.8 | 8 | Citations (PDF) |
| 126 | Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes | 2.2 | 23 | Citations (PDF) |
| 127 | The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes | 4.2 | 29 | Citations (PDF) |
| 128 | Outcomes of transurethral resection of the prostate in unobstructed patients with concomitant detrusor underactivity | 1.7 | 13 | Citations (PDF) |
| 129 | Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent | 2.2 | 11 | Citations (PDF) |
| 130 | Ureteral location is associated with survival outcomes in upper tract urothelial carcinoma: A population‐based analysis | 1.7 | 9 | Citations (PDF) |
| 131 | Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project) | 2.3 | 46 | Citations (PDF) |
| 132 | COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series | 2.2 | 121 | Citations (PDF) |
| 133 | How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? | 1.5 | 19 | Citations (PDF) |
| 134 | Can Bone Compaction Improve Primary Implant Stability? An In Vitro Comparative Study with Osseodensification Technique | 2.1 | 43 | Citations (PDF) |
| 135 | Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study | 3.8 | 28 | Citations (PDF) |
| 136 | Can Teledentistry Improve the Monitoring of Patients during the Covid-19 Dissemination? A Descriptive Pilot Study | 2.9 | 133 | Citations (PDF) |
| 137 | Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors | 1.2 | 4 | Citations (PDF) |
| 138 | Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma | 2.3 | 12 | Citations (PDF) |
| 139 | Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma | 5.8 | 45 | Citations (PDF) |
| 140 | Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study | 1.7 | 50 | Citations (PDF) |
| 141 | Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies | 4.4 | 24 | Citations (PDF) |
| 142 | An Uncommon Case of Plasma Cell Mucositis of the Tongue in a Young Man | 0.5 | 4 | Citations (PDF) |
| 143 | Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells | 12.5 | 70 | Citations (PDF) |
| 144 | Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection | 1.4 | 18 | Citations (PDF) |
| 145 | Early and Late Efficacy on Wound Healing of Silver Nanoparticle Gel in Males after Circumcision | 2.5 | 10 | Citations (PDF) |
| 146 | Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy | 3.0 | 5 | Citations (PDF) |
| 147 | Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years | 2.0 | 37 | Citations (PDF) |
| 148 | Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses | 5.1 | 219 | Citations (PDF) |
| 149 | Primary Stability of Three Different Osteotomy Techniques in Medullary Bone: An in Vitro Study | 2.8 | 30 | Citations (PDF) |
| 150 | Endocrine disruptors and thyroid autoimmunity | 5.1 | 67 | Citations (PDF) |
| 151 | Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset | 1.8 | 21 | Citations (PDF) |
| 152 | Impact of Robotic Surgery on Sick Leave and Return to Work in Patients Undergoing Radical Prostatectomy: An Evidence-Based Analysis | 1.3 | 8 | Citations (PDF) |
| 153 | Teprotumumab for the Treatment of Active Thyroid Eye Disease | 34.5 | 659 | Citations (PDF) |
| 154 | Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy | 5.1 | 164 | Citations (PDF) |
| 155 | Letter to the Editor: “Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection” | 8.2 | 8 | Citations (PDF) |
| 156 | Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients | 0.9 | 9 | Citations (PDF) |
| 157 | Protective Effects of Myo-Inositol and Selenium on Cadmium-Induced Thyroid Toxicity in Mice | 4.4 | 43 | Citations (PDF) |
| 158 | The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER’S gangrene: a retrospective multi-institutional cohort study | 2.2 | 41 | Citations (PDF) |
| 159 | Serum testosterone and obesity in prostate cancer biology: a call for health promotion in the ageing male | 2.7 | 16 | Citations (PDF) |
| 160 | The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature | 2.2 | 47 | Citations (PDF) |
| 161 | Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group | 2.2 | 8 | Citations (PDF) |
| 162 | How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study | 2.2 | 3 | Citations (PDF) |
| 163 | Evaluation of local hemostatic efficacy after dental extractions in patients taking antiplatelet drugs: a randomized clinical trial | 2.7 | 47 | Citations (PDF) |
| 164 | Endogenous testosterone mirrors prostate cancer aggressiveness: correlation between basal testosterone serum levels and prostate cancer European Urology Association clinical risk classes in a large cohort of Caucasian patients | 1.4 | 12 | Citations (PDF) |
| 165 | Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) | 0.9 | 22 | Citations (PDF) |
| 166 | Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study | 4.2 | 84 | Citations (PDF) |
| 167 | Neoadjuvant Strategies Before Radical Prostatectomy for High Risk Prostate Cancer in the Era of New Hormonal Agents | 2.1 | 11 | Citations (PDF) |
| 168 | COVID-19 is a New Challenge for Dental Practitioners: Advice on Patients’ Management from Prevention of Cross Infections to Telemedicine | 0.5 | 28 | Citations (PDF) |
| 169 | Outcomes and predictors of benign histology in patients undergoing robotic partial or radical nephrectomy for renal masses: a multicenter study | 0.5 | 3 | Citations (PDF) |
| 170 | Association of glomerular hyperfiltration with serum chemokine levels and metabolic features in prepubertal children with overweight/obesity | 3.2 | 3 | Citations (PDF) |
| 171 | Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database | 0.5 | 4 | Citations (PDF) |
| 172 | The Covid-19, Epidemiology, Clinic and Prevention | 1.5 | 0 | Citations (PDF) |
| 173 | The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results | 2.7 | 16 | Citations (PDF) |
| 174 | Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years | 2.3 | 54 | Citations (PDF) |
| 175 | The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition | 4.4 | 92 | Citations (PDF) |
| 176 | Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis | 1.1 | 23 | Citations (PDF) |
| 177 | Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors | 2.3 | 30 | Citations (PDF) |
| 178 | Myo-inositol in the protection from cadmium-induced toxicity in mice kidney: An emerging nutraceutical challenge | 3.5 | 56 | Citations (PDF) |
| 179 | How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder | 1.8 | 14 | Citations (PDF) |
| 180 | <p>Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes</p> | 2.7 | 23 | Citations (PDF) |
| 181 | Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) | 2.3 | 9 | Citations (PDF) |
| 182 | Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? | 5.9 | 35 | Citations (PDF) |
| 183 | Immune and Inflammatory Cells in Thyroid Cancer Microenvironment | 4.4 | 226 | Citations (PDF) |
| 184 | Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index | 2.3 | 41 | Citations (PDF) |
| 185 | Recent advances in precision medicine for the treatment of anaplastic thyroid cancer | 0.9 | 3 | Citations (PDF) |
| 186 | On-clamp versus off-clamp robotic partial nephrectomy: A systematic review and meta-analysis | 0.6 | 48 | Citations (PDF) |
| 187 | Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma | 1.1 | 5 | Citations (PDF) |
| 188 | Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies | 4.4 | 93 | Citations (PDF) |
| 189 | Chemokines in hyperthyroidism | 1.0 | 29 | Citations (PDF) |
| 190 | Peri-Operative Outcomes after Open and Robot-Assisted Radical Cystectomy by Using an Advanced Bipolar Seal and Cut Technology (Caiman®): A Prospective, Comparative, and Multi-Institutional Study | 0.9 | 7 | Citations (PDF) |
| 191 | Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration | 3.2 | 76 | Citations (PDF) |
| 192 | Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy | 7.1 | 23 | Citations (PDF) |
| 193 | Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma | 2.8 | 18 | Citations (PDF) |
| 194 | Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is Needed | 16.9 | 27 | Citations (PDF) |
| 195 | Genotoxicity Evaluation of the Soybean Isoflavone Genistein in Human Papillary Thyroid Cancer Cells. Study of Its Potential Use in Thyroid Cancer Therapy | 2.3 | 10 | Citations (PDF) |
| 196 | PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications | 4.4 | 45 | Citations (PDF) |
| 197 | Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study | 2.3 | 23 | Citations (PDF) |
| 198 | Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) | 1.4 | 12 | Citations (PDF) |
| 199 | Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy | 3.2 | 46 | Citations (PDF) |
| 200 | The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy | 2.2 | 14 | Citations (PDF) |
| 201 | The Simplified
PA
DUA
RE
nal (
SPARE
) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy | 3.2 | 72 | Citations (PDF) |
| 202 | The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases | 5.1 | 23 | Citations (PDF) |
| 203 | Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy | 5.1 | 533 | Citations (PDF) |
| 204 | Autoimmunity and the endocrine system: Thyroid, hypophysis and pregnancy | 5.1 | 0 | Citations (PDF) |
| 205 | Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study | 1.8 | 20 | Citations (PDF) |
| 206 | Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the
RECOR
d 2 project) | 3.2 | 28 | Citations (PDF) |
| 207 | The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series | 7.1 | 133 | Citations (PDF) |
| 208 | Gastrointestinal Malabsorption of Thyroxine | 24.6 | 141 | Citations (PDF) |
| 209 | Tumour contact surface area as a predictor of postoperative complications and renal function in patients undergoing partial nephrectomy for renal tumours | 3.2 | 22 | Citations (PDF) |
| 210 | Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) | 2.2 | 28 | Citations (PDF) |
| 211 | Renal surgery for the older population: time for a paradigm shift? Data from the RESURGE project | 2.7 | 5 | Citations (PDF) |
| 212 | Safety of on- vs off-clamp robotic partial nephrectomy: per-protocol analysis from the data of the CLOCK randomized trial | 2.2 | 53 | Citations (PDF) |
| 213 | Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis | 2.2 | 41 | Citations (PDF) |
| 214 | How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection | 2.2 | 4 | Citations (PDF) |
| 215 | Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases | 2.2 | 79 | Citations (PDF) |
| 216 | Predictors of the Transition from Off to On Clamp Approach during Ongoing Robotic Partial Nephrectomy: Data from the CLOCK Randomized Clinical Trial | 4.2 | 42 | Citations (PDF) |
| 217 | Sunitinib in the Treatment of Thyroid Cancer | 2.9 | 89 | Citations (PDF) |
| 218 | MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer. | 0.3 | 0 | Citations (PDF) |
| 219 | MON-564 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With L-thyroxine (L-T4) In Soft Gel Capsule Formulation | 0.3 | 0 | Citations (PDF) |
| 220 | MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases | 0.3 | 0 | Citations (PDF) |
| 221 | MON-625 Serum Tsh Levels Normalisation In Patients With Celiac Disease After The Switch From Oral L-t4 In Tablet Form To L-t4 In Liquid Formulation | 0.3 | 0 | Citations (PDF) |
| 222 | MON-565 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With Oral Liquid L-thyroxine (L-T4) Formulation | 0.3 | 0 | Citations (PDF) |
| 223 | MON-LB102 Liquid L-Thyroxine Can Maintain Stable TSH Values in Patients with Hypothyroidism: A Prospective Study | 0.3 | 0 | Citations (PDF) |
| 224 | Minimally Invasive Radical Prostatectomy after Previous Bladder Outlet Surgery: A Systematic Review and Pooled Analysis of Comparative Studies | 4.2 | 13 | Citations (PDF) |
| 225 | Role of Clinical and Surgical Factors for the Prediction of Immediate, Early and Late Functional Results, and its Relationship with Cardiovascular Outcome after Partial Nephrectomy: Results from the Prospective Multicenter RECORd 1 Project | 4.2 | 43 | Citations (PDF) |
| 226 | Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature | 6.8 | 82 | Citations (PDF) |
| 227 | Circulating thyrotropin is upregulated by estradiol | 1.0 | 11 | Citations (PDF) |
| 228 | Current and future immunotherapies for thyroid cancer | 2.5 | 52 | Citations (PDF) |
| 229 | Can Autofluorescence Guide Surgeons in the Treatment of Medication-Related Osteonecrosis of the Jaw? A Prospective Feasibility Study | 1.7 | 56 | Citations (PDF) |
| 230 | External Validation of the Arterial-Based Complexity Score and First Head-to-Head Comparison With the R.E.N.A.L. and PADUA Scores and C-index | 2.3 | 10 | Citations (PDF) |
| 231 | CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide | 2.8 | 4 | Citations (PDF) |
| 232 | Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells | 2.8 | 5 | Citations (PDF) |
| 233 | Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study | 1.6 | 20 | Citations (PDF) |
| 234 | Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration | 3.8 | 26 | Citations (PDF) |
| 235 | Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells | 2.8 | 11 | Citations (PDF) |
| 236 | Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo | 2.8 | 23 | Citations (PDF) |
| 237 | Endocrine disorders associated with hepatitis C virus chronic infection | 6.8 | 16 | Citations (PDF) |
| 238 | Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo | 2.8 | 42 | Citations (PDF) |
| 239 | The protective effect of myo-inositol on human thyrocytes | 6.8 | 14 | Citations (PDF) |
| 240 | Myo-inositol in autoimmune thyroiditis, and hypothyroidism | 6.8 | 35 | Citations (PDF) |
| 241 | Gut microbiota and Hashimoto’s thyroiditis | 6.8 | 128 | Citations (PDF) |
| 242 | Thyroid disorders induced by checkpoint inhibitors | 6.8 | 104 | Citations (PDF) |
| 243 | Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the A rt and New Perspectives with Patents Recently Applied | 3.4 | 26 | Citations (PDF) |
| 244 | Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis | 3.8 | 56 | Citations (PDF) |
| 245 | The Association of Sjögren Syndrome and Autoimmune Thyroid Disorders | 3.8 | 44 | Citations (PDF) |
| 246 | Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis | 3.8 | 21 | Citations (PDF) |
| 247 | A patient-specific treatment model for Graves’ hyperthyroidism | 1.4 | 26 | Citations (PDF) |
| 248 | Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma | 2.1 | 100 | Citations (PDF) |
| 249 | Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial | 2.1 | 13 | Citations (PDF) |
| 250 | Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study | 2.2 | 41 | Citations (PDF) |
| 251 | Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study | 2.7 | 33 | Citations (PDF) |
| 252 | Deregulated expression of VHL mRNA variants in papillary thyroid cancer | 3.4 | 11 | Citations (PDF) |
| 253 | Teprotumumab for Thyroid-Associated Ophthalmopathy | 34.5 | 682 | Citations (PDF) |
| 254 | BREG cells in Hashimoto's thyroiditis isolated or associated to further organ-specific autoimmune diseases | 2.6 | 32 | Citations (PDF) |
| 255 | Novel treatment options for anaplastic thyroid cancer | 2.9 | 14 | Citations (PDF) |
| 256 | Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells | 13.4 | 35 | Citations (PDF) |
| 257 | External histopathological validation of the surface-intermediate-base margin score | 1.8 | 11 | Citations (PDF) |
| 258 | Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification | 2.3 | 25 | Citations (PDF) |
| 259 | Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer | 3.8 | 7 | Citations (PDF) |
| 260 | In Patients With Subclinical Hypothyroidism While in Therapy With Tablet L-T4, the Liquid L-T4 Formulation is More Effective in Restoring Euthyroidism | 3.3 | 27 | Citations (PDF) |
| 261 | International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement | 7.1 | 98 | Citations (PDF) |
| 262 | Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer | 8.6 | 32 | Citations (PDF) |
| 263 | Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory | 4.4 | 60 | Citations (PDF) |
| 264 | Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis | 7.1 | 36 | Citations (PDF) |
| 265 | Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update | 5.0 | 47 | Citations (PDF) |
| 266 | Environmental Issues in Thyroid Diseases | 3.8 | 157 | Citations (PDF) |
| 267 | Systemic Lupus Erythematosus and Thyroid Autoimmunity | 3.8 | 49 | Citations (PDF) |
| 268 | Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity | 3.8 | 28 | Citations (PDF) |
| 269 | Refractory Hypothyroidism Due to Improper Storage of Levothyroxine Tablets | 3.8 | 18 | Citations (PDF) |
| 270 | Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia | 3.8 | 25 | Citations (PDF) |
| 271 | Serum Thyrotropin and Phase of the Menstrual Cycle | 3.8 | 13 | Citations (PDF) |
| 272 | Associations between Systemic Sclerosis and Thyroid Diseases | 3.8 | 27 | Citations (PDF) |
| 273 | Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations | 2.1 | 13 | Citations (PDF) |
| 274 | HCV-Related Rheumatic Manifestations and Therapeutic Strategies | 2.1 | 8 | Citations (PDF) |
| 275 | Thyroid nodules and thyroid autoimmunity in the context of environmental pollution | 6.8 | 58 | Citations (PDF) |
| 276 | Pediatric Differentiated Thyroid Cancer: When to Perform Conservative and Radical Surgery | 1.6 | 10 | Citations (PDF) |
| 277 | Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis | 2.5 | 21 | Citations (PDF) |
| 278 | End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline | 2.1 | 56 | Citations (PDF) |
| 279 | Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma | 4.2 | 58 | Citations (PDF) |
| 280 | The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders | 6.8 | 26 | Citations (PDF) |
| 281 | Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up | 2.1 | 33 | Citations (PDF) |
| 282 | The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer | 2.5 | 22 | Citations (PDF) |
| 283 | Features, risk factors and clinical outcome of “very late” recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up | 1.7 | 17 | Citations (PDF) |
| 284 | International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement | 7.1 | 98 | Citations (PDF) |
| 285 | The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients | 7.1 | 197 | Citations (PDF) |
| 286 | Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues | 16.9 | 3 | Citations (PDF) |
| 287 | Inositol(s) in thyroid function, growth and autoimmunity | 6.8 | 40 | Citations (PDF) |
| 288 | Smoke and autoimmunity: The fire behind the disease | 7.1 | 182 | Citations (PDF) |
| 289 | Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up | 7.1 | 15 | Citations (PDF) |
| 290 | Novel Therapies for Thyroid Autoimmune Diseases | 2.5 | 26 | Citations (PDF) |
| 291 | Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) | 1.4 | 123 | Citations (PDF) |
| 292 | Comparison of Perioperative Morbidity of Radical Cystectomy With Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients | 2.3 | 13 | Citations (PDF) |
| 293 | TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation | 2.2 | 74 | Citations (PDF) |
| 294 | Certain HLA alleles are associated with stress-triggered Graves’ disease and influence its course | 2.5 | 41 | Citations (PDF) |
| 295 | Patients with lactose intolerance absorb liquid levothyroxine
better than tablet levothyroxine | 2.5 | 29 | Citations (PDF) |
| 296 | Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy? | 1.5 | 79 | Citations (PDF) |
| 297 | Tyrosine Kinase Inhibitors for the Therapy of Anaplastic Thyroid Cancer | 0.6 | 6 | Citations (PDF) |
| 298 | Thyroid Diseases and Hepatitis C Chronic Infection | 0.0 | 0 | Citations (PDF) |
| 299 | Molecular Targeted Therapies of Aggressive Thyroid Cancer | 3.8 | 63 | Citations (PDF) |
| 300 | Deregulated Expression of Aurora Kinases Is Not a Prognostic Biomarker in Papillary Thyroid Cancer Patients | 2.3 | 28 | Citations (PDF) |
| 301 | Intrinsic Ureteral Endometriosis: Description of a Striking Instance | 0.6 | 0 | Citations (PDF) |
| 302 | Differences in Morbidity of Neobladder versus Ileal Conduit: A Matched Pair Analysis on 134 Patients | 0.6 | 0 | Citations (PDF) |
| 303 | Selective use of vandetanib in the treatment of&nbsp;thyroid cancer | 6.9 | 32 | Citations (PDF) |
| 304 | Peroxisome Proliferator-Activated Receptor-γin Thyroid Autoimmunity | 6.2 | 23 | Citations (PDF) |
| 305 | Positive Surgical Margin Status after Minimally Invasive Radical Prostatectomy: a Multicenter Study | 0.6 | 0 | Citations (PDF) |
| 306 | New Therapies for Dedifferentiated Papillary Thyroid Cancer | 4.4 | 56 | Citations (PDF) |
| 307 | Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a–T1b Renal Mass and Normal Preoperative Renal Function | 2.1 | 260 | Citations (PDF) |
| 308 | Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection | 3.5 | 76 | Citations (PDF) |
| 309 | Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature | 7.1 | 137 | Citations (PDF) |
| 310 | Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients | 1.7 | 13 | Citations (PDF) |
| 311 | TriMatchcomparison of the efficacy ofFloSealversusTachoSilversus no hemostatic agents for partial nephrectomy: Results from a large multicenter dataset | 1.7 | 41 | Citations (PDF) |
| 312 | Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis | 1.9 | 13 | Citations (PDF) |
| 313 | CXCL10 in psoriasis | 2.4 | 60 | Citations (PDF) |
| 314 | Autoimmune thyroid disorders | 7.1 | 838 | Citations (PDF) |
| 315 | A Prospective, Multicenter Evaluation of Predictive Factors for Positive Surgical Margins After Nephron-Sparing Surgery for Renal Cell Carcinoma: The RECORd1 Italian Project | 2.3 | 45 | Citations (PDF) |
| 316 | CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation | 2.5 | 15 | Citations (PDF) |
| 317 | Oral l-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study | 2.5 | 47 | Citations (PDF) |
| 318 | Calcitonin, as SMS 201–995, ameliorates the VIPoma syndrome | 2.8 | 0 | Citations (PDF) |
| 319 | CD38 autoimmunity: Recent advances and relevance to human diabetes | 2.8 | 19 | Citations (PDF) |
| 320 | Thyroid involvement in hepatitis C — Associated mixed cryoglobulinemia | 1.8 | 12 | Citations (PDF) |
| 321 | IP-10 in Autoimmune Thyroiditis | 1.8 | 50 | Citations (PDF) |
| 322 | Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection | 3.5 | 25 | Citations (PDF) |
| 323 | The administration ofl-thyroxine as soft gel capsule or liquid solution | 5.0 | 92 | Citations (PDF) |
| 324 | Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn | 2.6 | 231 | Citations (PDF) |
| 325 | A multicentre matched‐pair analysis comparing robot‐assisted versus open partial nephrectomy | 3.2 | 86 | Citations (PDF) |
| 326 | CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo | 3.4 | 23 | Citations (PDF) |
| 327 | Cytokines and HCV-related autoimmune disorders | 2.7 | 28 | Citations (PDF) |
| 328 | The Percentage of Core Involved by Cancer Is the Best Predictor of Insignificant Prostate Cancer, According to an Updated Definition (Tumor Volume up to 2.5 cm3): Analysis of a Cohort of 210 Consecutive Patients With Low-risk Disease | 1.4 | 19 | Citations (PDF) |
| 329 | The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy | 2.3 | 23 | Citations (PDF) |
| 330 | Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases | 7.1 | 565 | Citations (PDF) |
| 331 | CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo | 4.0 | 50 | Citations (PDF) |
| 332 | Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ | 7.1 | 33 | Citations (PDF) |
| 333 | Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro | 1.8 | 17 | Citations (PDF) |
| 334 | CXCR3, CXCL10 and type 1 diabetes | 10.5 | 116 | Citations (PDF) |
| 335 | Reply | 1.4 | 0 | Citations (PDF) |
| 336 | Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. | 5.6 | 18 | Citations (PDF) |
| 337 | Detection of non-Hodgkin lymphoma by [18F]FDG-PET/CT in a patient with differentiated thyroid cancer | 2.5 | 0 | Citations (PDF) |
| 338 | Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology? | 2.4 | 45 | Citations (PDF) |
| 339 | Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 | 2.2 | 14 | Citations (PDF) |
| 340 | Sorafenib and Thyroid Cancer | 6.2 | 54 | Citations (PDF) |
| 341 | Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: Modulation by peroxisome proliferator-activated receptor γ agonists | 1.1 | 19 | Citations (PDF) |
| 342 | Incidence of Thyroid Disorders in Systemic Sclerosis: Results from a Longitudinal Follow-Up | 4.0 | 29 | Citations (PDF) |
| 343 | Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project) | 2.1 | 95 | Citations (PDF) |
| 344 | Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 | 1.7 | 7 | Citations (PDF) |
| 345 | Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis’s MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokine | 3.5 | 18 | Citations (PDF) |
| 346 | Systemic sclerosis and cryoglobulinemia: Our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature | 7.1 | 56 | Citations (PDF) |
| 347 | Non-cancer atherosclerotic effects associated with environmental and therapeutic radiation doses: The Chernobyl thyroid cancer children study | 2.2 | 2 | Citations (PDF) |
| 348 | Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study | 1.8 | 20 | Citations (PDF) |
| 349 | Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts | 1.7 | 11 | Citations (PDF) |
| 350 | Impact of Clinical and Histopathological Parameters on Disease Specific Survival in Patients with Collecting Duct Renal Cell Carcinoma: Development of a Disease Specific Risk Model | 4.2 | 38 | Citations (PDF) |
| 351 | Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma | 3.5 | 38 | Citations (PDF) |
| 352 | Antithyroid medications and psychosis | 2.6 | 9 | Citations (PDF) |
| 353 | Short and Medium Term Oncological Results after Robot-Assisted Prostatectomy: A Comparative Prospective Non Randomized Study | 0.6 | 2 | Citations (PDF) |
| 354 | Increase of Interferon-γ Inducible CXCL9 and CXCL11 Serum Levels in Patients with Active Graves' Disease and Modulation by Methimazole Therapy | 4.4 | 19 | Citations (PDF) |
| 355 | High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia | 2.2 | 8 | Citations (PDF) |
| 356 | Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project) | 2.2 | 55 | Citations (PDF) |
| 357 | Results of Targeted Therapies for M1 Renal Cell Carcinoma: Our Experience | 0.6 | 2 | Citations (PDF) |
| 358 | ProACT (Adjustable Continence Therapy) Implants in Case of Failure of other Techniques for Urinary Incontinence | 0.6 | 1 | Citations (PDF) |
| 359 | T&G: An Elementary Integrated Prognostic System for Renal Carcinoma N0 M0 | 0.6 | 0 | Citations (PDF) |
| 360 | Urinary Tract Endometriosis | 0.6 | 21 | Citations (PDF) |
| 361 | An Iron Regulatory Gene Signature in Breast Cancer: More than a Prognostic Genetic Profile? | 2.3 | 3 | Citations (PDF) |
| 362 | High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 | 1.7 | 8 | Citations (PDF) |
| 363 | Cytokines and HCV-Related Disorders | 4.8 | 97 | Citations (PDF) |
| 364 | Sliding-Clip Robotic Nephropexy | 0.6 | 2 | Citations (PDF) |
| 365 | Radiotherapy in Case of Locally Advanced Prostate Cancer: Long-Term follow-up in 223 Patients | 0.6 | 0 | Citations (PDF) |
| 366 | Hepatitis C is Associated with High Levels of Circulating N-Terminal Pro-Brain Natriuretic Peptide and Interleukin-6 | 0.6 | 3 | Citations (PDF) |
| 367 | High Serum Levels of CXC (CXCL10) and CC (CCL2) Chemokines in Untreated Essential Hypertension | 2.2 | 28 | Citations (PDF) |
| 368 | Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis | 1.9 | 18 | Citations (PDF) |
| 369 | Systemic Sclerosis Fibroblasts Show Specific Alterations of Interferon-γ and Tumor Necrosis Factor-α-induced Modulation of Interleukin 6 and Chemokine Ligand 2 | 2.3 | 16 | Citations (PDF) |
| 370 | Current treatment of hepatitis C-associated rheumatic diseases | 3.9 | 44 | Citations (PDF) |
| 371 | Clinical features and prognosis of patients with renal cancer and a second malignancy | 1.8 | 8 | Citations (PDF) |
| 372 | Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids | 6.6 | 38 | Citations (PDF) |
| 373 | Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer | 3.5 | 28 | Citations (PDF) |
| 374 | CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo | 4.0 | 54 | Citations (PDF) |
| 375 | Age related cardiovascular dysfunction and effects of physical activity | 1.9 | 3 | Citations (PDF) |
| 376 | RET TKI: Potential Role in Thyroid Cancers | 4.2 | 40 | Citations (PDF) |
| 377 | Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves’ ophthalmopathy fibroblasts and preadipocytes | 3.4 | 14 | Citations (PDF) |
| 378 | Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi‐institutional study | 3.2 | 90 | Citations (PDF) |
| 379 | Prognostic factors in a large multi‐institutional series of papillary renal cell carcinoma | 3.2 | 27 | Citations (PDF) |
| 380 | Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series | 3.2 | 156 | Citations (PDF) |
| 381 | Prognostic role of tumour multifocality in renal cell carcinoma | 3.2 | 15 | Citations (PDF) |
| 382 | Surgical treatment of atypical metastasis from renal cell carcinoma (RCC) | 3.2 | 36 | Citations (PDF) |
| 383 | External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma | 2.2 | 5 | Citations (PDF) |
| 384 | Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis | 1.9 | 16 | Citations (PDF) |
| 385 | CXC-Chemokines and Thyroid Associated Autoimmunity | 0.0 | 0 | Citations (PDF) |
| 386 | IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls | 1.4 | 12 | Citations (PDF) |
| 387 | Early Menopause Is Associated With Lack of Response to Antiviral Therapy in Women With Chronic Hepatitis C | 0.9 | 105 | Citations (PDF) |
| 388 | Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10 | 3.5 | 68 | Citations (PDF) |
| 389 | Simple Enucleation is Equivalent to Traditional Partial Nephrectomy for Renal Cell Carcinoma: Results of a Nonrandomized, Retrospective, Comparative Study | 4.2 | 158 | Citations (PDF) |
| 390 | Cytokines (interferon-γ and tumor necrosis factor–α)-induced nuclear factor–κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone | 9.1 | 35 | Citations (PDF) |
| 391 | Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease | 3.1 | 24 | Citations (PDF) |
| 392 | Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells | 5.1 | 26 | Citations (PDF) |
| 393 | Lobectomy versus total thyroidectomy in children with post-Chernobyl thyroid cancer: a 15 year follow-up | 2.5 | 5 | Citations (PDF) |
| 394 | Increase of Circulating CXCL9 and CXCL11 Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis | 4.0 | 65 | Citations (PDF) |
| 395 | Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer | 4.0 | 74 | Citations (PDF) |
| 396 | Ductal Carcinoma of the Prostate: Impact on Survival and Therapeutic Controversies of a Rare Tumor | 0.6 | 2 | Citations (PDF) |
| 397 | High Serum Levels of CXCL11 in Mixed Cryoglobulinemia Are Associated with Increased Circulating Levels of Interferon-γ | 2.3 | 17 | Citations (PDF) |
| 398 | Prevalence of thyroid dysfunctions in systemic lupus erythematosus | 9.1 | 94 | Citations (PDF) |
| 399 | Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed? | 2.1 | 220 | Citations (PDF) |
| 400 | Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma | 1.2 | 53 | Citations (PDF) |
| 401 | High circulating levels of N‐terminal pro‐brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia | 3.6 | 10 | Citations (PDF) |
| 402 | High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C | 1.9 | 18 | Citations (PDF) |
| 403 | Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts | 1.7 | 9 | Citations (PDF) |
| 404 | New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer | 3.9 | 31 | Citations (PDF) |
| 405 | N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-α Both Are Increased in Patients with Hepatitis C | 1.7 | 12 | Citations (PDF) |
| 406 | Interleukin-1β, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis | 1.7 | 15 | Citations (PDF) |
| 407 | Serum Concentrations of Interleukin 1ß, CXCL10, and Interferon-γ in Mixed Cryoglobulinemia Associated with Hepatitis C Infection | 2.3 | 23 | Citations (PDF) |
| 408 | Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study | 4.0 | 56 | Citations (PDF) |
| 409 | CXCL9 and CXCL11 Chemokines Modulation by Peroxisome Proliferator-Activated Receptor-α Agonists Secretion in Graves’ and Normal Thyrocytes | 4.0 | 64 | Citations (PDF) |
| 410 | In vitro and in vivo study on the antioxidant activity of dexrazoxane | 6.6 | 21 | Citations (PDF) |
| 411 | Cardiovascular complications in patients with pheochromocytoma: A mini-review | 6.6 | 104 | Citations (PDF) |
| 412 | Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy | 6.6 | 22 | Citations (PDF) |
| 413 | Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: Modulation by peroxisome proliferator-activated receptor-gamma agonists | 3.5 | 59 | Citations (PDF) |
| 414 | CXCL9 and CXCL11 Chemokines Modulation by Peroxisome Proliferator-Activated Receptor-α Agonists Secretion in Graves’ and Normal Thyrocytes | 24.6 | 0 | Citations (PDF) |
| 415 | Monokine Induced by Interferon γ (IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves’ Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists | 4.0 | 100 | Citations (PDF) |
| 416 | Serum levels of proinflammatory cytokines interleukin‐1β, interleukin‐6, and tumor necrosis factor α in mixed cryoglobulinemia | 6.1 | 40 | Citations (PDF) |
| 417 | High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia | 2.2 | 23 | Citations (PDF) |
| 418 | Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells | 2.3 | 65 | Citations (PDF) |
| 419 | Spontaneous and bleomycin‐induced chromosome damage in non cancer thyroid patients | 3.0 | 9 | Citations (PDF) |
| 420 | Endocrine manifestations of hepatitis C virus infection | 6.0 | 99 | Citations (PDF) |
| 421 | Cardiac remodeling in patients with primary aldosteronism | 2.8 | 23 | Citations (PDF) |
| 422 | 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet | 4.2 | 116 | Citations (PDF) |
| 423 | Clinicopathologic and molecular disease prognostication for papillary thyroid cancer | 2.5 | 7 | Citations (PDF) |
| 424 | CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C | 2.5 | 22 | Citations (PDF) |
| 425 | CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis | 1.7 | 12 | Citations (PDF) |
| 426 | Carotid integrated backscatter analysis in patients with subclinical hypothyroidism | 2.3 | 7 | Citations (PDF) |
| 427 | Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study | 2.9 | 77 | Citations (PDF) |
| 428 | Primary cell cultures from anaplastic thyroid cancer obtained by fine‐needle aspiration used for chemosensitivity tests | 2.3 | 66 | Citations (PDF) |
| 429 | Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia | 7.1 | 91 | Citations (PDF) |
| 430 | Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7cm | 2.1 | 110 | Citations (PDF) |
| 431 | α-Chemokine CXCL10 and β-chemokine CCL2 serum levels in patients with hepatitis C–associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis | 9.1 | 44 | Citations (PDF) |
| 432 | Dedifferentiated thyroid cancer: A therapeutic challenge | 6.6 | 100 | Citations (PDF) |
| 433 | High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis | 3.5 | 56 | Citations (PDF) |
| 434 | High Values of CXCL10 Serum Levels in Mixed Cryoglobulinemia Associated With Hepatitis C Infection | 0.7 | 65 | Citations (PDF) |
| 435 | High serum levels of CXC chemokine ligand 10 in untreated essential hypertension | 2.5 | 14 | Citations (PDF) |
| 436 | High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis | 3.1 | 44 | Citations (PDF) |
| 437 | Thyroid-Associated Ophthalmopathy and TSH Receptor Autoantibodies in Nonmetastatic Thyroid Cancer After Total Thyroidectomy | 0.9 | 9 | Citations (PDF) |
| 438 | Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis | 5.5 | 7 | Citations (PDF) |
| 439 | Iodine-131 Given for Therapeutic Purposes Modulates Differently Interferon-γ-Inducible α-Chemokine CXCL10 Serum Levels in Patients with Active Graves’ Disease or Toxic Nodular Goiter | 4.0 | 67 | Citations (PDF) |
| 440 | Induction of chromatid-type aberrations in peripheral lymphocytes of hospital workers exposed to very low doses of radiation | 2.0 | 16 | Citations (PDF) |
| 441 | Thyroid Cancer in HCV-Related Chronic Hepatitis Patients: A Case-Control Study | 4.4 | 72 | Citations (PDF) |
| 442 | HCV-related autoimmune and neoplastic disorders: the HCV syndrome | 2.5 | 95 | Citations (PDF) |
| 443 | The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol | 3.2 | 90 | Citations (PDF) |
| 444 | B-cells and mixed cryoglobulinemia | 7.1 | 66 | Citations (PDF) |
| 445 | Thyroid Disorders in Chronic Hepatitis C Virus Infection | 4.4 | 124 | Citations (PDF) |
| 446 | Heart rate variability and QT dispersion in patients with subclinical hypothyroidism | 6.6 | 57 | Citations (PDF) |
| 447 | Effect of l-thyroxine treatment on left ventricular function in subclinical hypothyroidism | 6.6 | 33 | Citations (PDF) |
| 448 | Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing | 3.5 | 79 | Citations (PDF) |
| 449 | Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules | 2.0 | 8 | Citations (PDF) |
| 450 | Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients | 3.2 | 90 | Citations (PDF) |
| 451 | Increase of interferon‐γ‐inducible CXC chemokine CXCL10 serum levels in patients with active Graves’ disease, and modulation by methimazole therapy | 2.3 | 69 | Citations (PDF) |
| 452 | Clinical Aspects and Surgical Treatment of Urinary Tract Endometriosis: Our Experience with 31 Cases | 2.1 | 129 | Citations (PDF) |
| 453 | Thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma in children | 1.8 | 9 | Citations (PDF) |
| 454 | Serum levels of the interferon-γ-inducible α chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy | 0.3 | 68 | Citations (PDF) |
| 455 | Prevalence of Hypothyroidism and Graves Disease in SarcoidosisChest, 2006, 130, 526-532 | 1.0 | 98 | Citations (PDF) |
| 456 | Interferon-γ-Inducible α-Chemokine CXCL10 Involvement in Graves’ Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists | 4.0 | 152 | Citations (PDF) |
| 457 | New trends in the treatment of undifferentiated carcinomas of the thyroid | 1.5 | 29 | Citations (PDF) |
| 458 | Age-Dependent Changes in CXC Chemokine Ligand 10 Serum Levels in Euthyroid Subjects | 1.7 | 24 | Citations (PDF) |
| 459 | Anti-CD38 Autoimmunity in Children with Newly Diagnosed Type 1 Diabetes Mellitus | 0.8 | 7 | Citations (PDF) |
| 460 | High Levels of Circulating CXC Chemokine Ligand 10 Are Associated with Chronic Autoimmune Thyroiditis and Hypothyroidism | 4.0 | 112 | Citations (PDF) |
| 461 | Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia | 0.5 | 69 | Citations (PDF) |
| 462 | Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients | 3.8 | 481 | Citations (PDF) |
| 463 | Surgical treatment of ureteral obstruction from endometriosis: our experience with thirteen cases | 1.4 | 55 | Citations (PDF) |
| 464 | Thyroid disorders in chronic hepatitis C | 2.0 | 213 | Citations (PDF) |
| 465 | Role of Neck Ultrasonography in the Follow-Up of Children Operated on for Thyroid Papillary Cancer | 4.4 | 97 | Citations (PDF) |
| 466 | Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients | 2.1 | 69 | Citations (PDF) |
| 467 | Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease | 3.3 | 47 | Citations (PDF) |
| 468 | Prolonged In Vitro Exposure to Autoantibodies Against CD38 Impairs the Function and Survival of Human Pancreatic Islets | 4.2 | 24 | Citations (PDF) |
| 469 | Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes | 7.5 | 54 | Citations (PDF) |
| 470 | DNA damage evaluated by alkaline single cell gel electrophoresis (SCGE) in children of Chernobyl, 10 years after the disaster | 2.0 | 17 | Citations (PDF) |
| 471 | Human Anti-CD38 Autoantibodies Raise Intracellular Calcium and Stimulate Insulin Release in Human Pancreatic Islets | 4.2 | 60 | Citations (PDF) |
| 472 | Chromosome aberrations in lymphocytes and clastogenic factors in plasma detected in Belarus children 10 years after Chernobyl accident | 2.0 | 22 | Citations (PDF) |
| 473 | Cytogenetic damage in lymphocytes of healthy and thyroid tumor-affected children from the Gomel region (Belarus) | 1.8 | 9 | Citations (PDF) |
| 474 | Completion Total Thyroidectomy in Children With Thyroid Cancer Secondary to the Chernobyl Accident | 2.4 | 78 | Citations (PDF) |
| 475 | Intravenous Immunoglobulin versus Corticosteroid in Treatment of Graves' Ophthalmopathy | 4.4 | 77 | Citations (PDF) |
| 476 | O XIII.3 Cytogenetic investigation on children exposed to Tchernobyl radioactive fallout: 10 years later | 1.8 | 0 | Citations (PDF) |
| 477 | Is Occupationally Induced Exposure to Radiation a Risk Factor for Thyroid Nodule Formation? | 0.1 | 19 | Citations (PDF) |
| 478 | Thyroid and non organ specific autoantibodies in patients with thyroid-associated ophthalmopathy: Immune modulation by intravenous immunoglobulin | 1.3 | 0 | Citations (PDF) |
| 479 | Epidemiologic and Clinical Evaluation of Thyroid Cancer in Children from the Gomel Region (Belarus) | 2.3 | 67 | Citations (PDF) |
| 480 | Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos 1996, 30, 588-595 | | 43 | Citations (PDF) |
| 481 | Role of Neck Ultrasonography in the Follow-up of Patients Operated on for Thyroid Cancer | 4.4 | 185 | Citations (PDF) |
| 482 | Risk of thyroid nodules in subjects occupationally exposed to radiation: a cross sectional study. | 2.8 | 25 | Citations (PDF) |
| 483 | Pretibial Myxedema and High-Dose Intravenous Immunoglobulin Treatment | 4.4 | 68 | Citations (PDF) |
| 484 | Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts | 0.4 | 49 | Citations (PDF) |
| 485 | Clinical Picture of Endemic Cretinism in Central Apennines (Montefeltro) | 4.4 | 33 | Citations (PDF) |
| 486 | In vitro solubilization of deposits of IgG immune complexes by gamma-globulins in patients with graves‘disease, graves’ ophthalmopathy, pretibial myxoedema and hashimoto's thyroiditis. | 9.1 | 5 | Citations (PDF) |
| 487 | Somatostatin effect in postprandial hypoglycemia | 9.1 | 9 | Citations (PDF) |
| 488 | Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome. | 0.1 | 3 | Citations (PDF) |
| 489 | Interaction of the thyrotropin receptor on rat FRTL-5 thyroid cells with thyrotropin and a thyrotropin-stimulating autoantibody from Graves' patients | 2.1 | 7 | Citations (PDF) |
| 490 | Effect of the Antileukemic Agent L-Asparaginase on Thyroxine-Binding Globulin and Albumin Synthesis in Cultured Human Hepatoma (HEP G2) Cells* | 2.5 | 17 | Citations (PDF) |
| 491 | Thyroid dysfunctions induced by tyrosine kinase inhibitors | 2.6 | 53 | Citations (PDF) |
| 492 | COVID-19 in Italian patients with rheumatic autoimmune systemic diseases | 6.9 | 7 | Citations (PDF) |
| 493 | Nanoparticles in Thyroid Autoimmunity: Diagnostic and Therapeutic Applications | 2.5 | 0 | Citations (PDF) |
| 494 | Acetate Metabolism in Thyroid Cancer Progression | 4.4 | 0 | Citations (PDF) |
| 495 | Hashimoto's Thyroiditis Beyond Thyroid Hormones: A Systematic Review of Autoimmunity, Inflammation, and Multidimensional Burden | 2.3 | 0 | Citations (PDF) |
